Jun 19, 2004
Thank you for the excellent work you do on this site. Your help is really appreciated.
For those starting their first HAART regimen and wishing to start on a PI-sparing combination, it seems that Combivir/Sustiva has always been an excellent choice. However, I seem to be hearing of more and more people starting with the combination of Viread/3TC/Sustiva. Given the opportunity for once a day dosing, low pill burden, a (relatively) low side-effect profile (particularly when compared with AZT) and a lower risk of developing lipoatrophy, do you now favour this regimen as a starting regimen or hasn't enough research been conducted to determine the long-term efficacy of this combination?
I have no prior drug-resistance to any HIV meds and would like to take this combination when the time comes for me to start meds as it seems so attractive compared to other combinations.
Response from Dr. Pierone
Hello and thanks for posting. I do favor the use of once daily regimens like Viread, Epivir, and Sustiva for initial management of HIV infection. There is nothing wrong with Combivir and Sustiva and we have many patients doing well on it for years. However, we now have long-term data on these newer regimens and they work quite and tend to have fewer side effects.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.